SPECTAlung open to patient entry
22 Jun 2015
EORTC, through SPECTAlung, participates in EU consortium validating blood-based cancer biomarkers
29 Apr 2015
EORTC values ICO –VHIO as partners in its pan-European SPECTAcolor network
30 Mar 2015
14M Genomics and the EORTC collaborate on genomic profiling for clinical trials
10 Mar 2015
SPECTAcolor viable next generation multinational cancer clinical trial infrastructure
14 Jan 2015
EORTC Medical Director Dr Vassilis Golfinopoulos talks about the aims of SPECTA
1 Dec 2014
Europe’s health policies ‘must change’ with stakeholders leaving their ‘comfort zones’
24 Oct 2014
1 year in, SPECTAcolor is a viable cancer research model!
19 Sep 2014
